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Bioactive glasses are capable of reacting with physiological fluids to form a hydroxyap-
atite (HA) layers. This layer, with similar composition than the mineral part of the bone, 
leads to firm bond between the glass and the tissue. Silicate based bioactive glasses 
commonly convert slowly and incompletely to HA due to their non-congruent dissolu-
tion. It was found in previous clinical studied that typical bioactive glass remains at the 
surgical site even 14 years’ post-surgery.  
The dissolution and reaction mechanism, leading to the precipitation of a HA layer is 
mainly due to the bioactive glass loose structure. However, such loose structure also 
inhibits any hot forming of the glass. Indeed, sintering of commercial bioactive glasses 
led to scaffolds with very low mechanical properties and partially to fully crystallized 
scaffolds. The surface crystallization of these glasses decreased their bioactivity. 
This thesis uses the glass S53P4 as a reference as it is well studied and commercially 
available. As for all commercially available silicate bioactive glasses, glass S53P4 can-
not be hot formed without crystallization and does not convert fully into HA. Thus, 
glasses with partial to almost full substitution of the SiO2 with B2O3 were developed. 
The aim is to define new glass composition that have thermal and structural properties 
allowing for heat sintering while converting faster to HA. In general, the addition of 
boron within the silicate glass led to a material more prone to dissolve in aqueous solu-
tion. The reaction of the glass and its conversion into hydroxyapatite was also faster. 
The glass labelled B25, B50 and B75 were found to be the most suited to be sintered 
into porous scaffolds. 
Scaffold were processed using three particles size (<250 µm, 250 – 500 µm and 
>500µm). The porosity was found to decrease with decreasing the particles size (at sim-
ilar sintering temperature) and increasing the sintering temperature (at constant particle 
size). All the scaffolds produced were found to be amorphous. Scaffolds (particle size 
250 – 500µm) with 50% overall porosity were immersed in SBF for up to 168h. The 
compression strength decreased with increasing the immersion time. All the scaffold 
maintained their ability to precipitate a HA layer at their surface. The newly developed 
glasses were found to be suitable for future, more sophisticated scaffold manufacturing 
for tissue engineering. 
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1. INTRODUCTION 
With the advancement in the medical science and engineering, there has always been an 
interest to ease medical complication by developing new methods and materials. For the 
sake of betterment of mankind various materials are being researched and innovated for 
use in humans. One of the biggest field in this innovation is biomaterials. According to 
Williams “A biomaterial is a substance that has been engineered to take a form which, 
alone or as part of a complex system, is used to direct, by control of interactions with 
components of living systems, the course of any therapeutic or diagnostic procedure, in 
human or veterinary medicine” (Williams 2009). Biomaterial is a broad subject and has 
been classified by various authors and administrations differently. In regards to the tis-
sue reaction, biomaterials can be: biotolerant (separated from the bone tissue by fibrous 
tissue), bioactive (that have property to form chemical bond with bone tissue) or bioin-
ert (no chemical reaction occur between implant and the tissue) (Bergmann 2013). This 
thesis focuses mainly on bioactive materials.  
A bioactive material is able to elicit a specific biological response at the interface of the 
material that results in the formation of a bond between the tissues and the material 
(Hench et al. 1972). Bioactive glasses are a subset of inorganic bioactive materials. 
They are capable of reacting with physiological fluids to form firm bonds to bone 
through the formation of hydroxyapatite layers, a main constituent of bone, and the bio-
logical interaction of collagen with the material surface (Hench, 1998). Bioactive glass-
es are osteoconductive, i.e., that they have the ability to grow new bones at their surface. 
They not only form a bond with hard but also with soft tissues. 45S5 (Bioglass®) and 
S53P4 (BonAlive®) are the most studied bioactive glass for biomedical applications. 
Both these glasses are FDA approved. 
The most studied bioactive glasses are silicate-, phosphate- and borate-based. Silicate 
based bioactive glass are the most commercially used bioactive glasses. They are used 
mainly as granules and coating in bone regeneration, dental, wound healing and maxil-
lofacial applications. Borate glasses have shown promising results in bone regeneration 
and angiogenesis (Bi et al. 2013) and phosphate glass have been found as alternative to 
silicate glass in bone repair and reconstruction (Clement et al. 1999). The main differ-
ence between these glasses being is the way in which they dissolve and react in vitro 
and in vivo. Silicate glasses are known to dissolve in a non-congruent manner, i.e. alka-
line and alkaline earth present in the glass are released at a higher rate than the Si ions 
that results in the formation of a thick Si-rich layer onto which the hydroxyapatite will 
precipitate (Hench 1998). At the contrary, phosphate and borate bioactive glasses de-
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grades in a congruent manner, i.e. that all ions are released at the same rate and the base 
glass composition does not change with respect to the immersion time (Bunker et al. 
1984, Massera et al. 2014a, Yao et al. 2007)). Often, this leads to a more control and a 
more complete dissolution.  
There has been an increasing interest in porous glasses for applications where bone in-
growth is needed. Especially, there is a clinical demand for artificial bone graft materi-
als or bioactive scaffolds that can stimulate bone regeneration by acting as temporary 
templates for vascularized bone growth (Amini et al. 2012). The scaffold should have 
an interconnected pore structure, with interconnected pore sizes that are greater than 
100 µm (Jones et al. 2003) but subsequent studies have shown better osteogenesis for 
implants with pores >300 μm (Tsuruga et al. 1997). Relatively larger pores favor direct 
osteogenesis, since they allow vascularization and high oxygenation. However, increase 
in porosity leads to poor mechanical properties. The compression strength of porous 
glassy implants has been achieved in the same order as that of cancellous bone (Jones et 
al. 2006). The compressive strength of cancellous bone is 2-12 MPa and that of cortical 
bone 100-230 MPa (Heikkilä 2011). To reach higher mechanical properties a higher 
sintering temperature is usually used. However, it was found that the high thermal 
treatment increases the strength, but also induced crystallization and reduces the porosi-
ty (Fagerlund 2012). There have been studies on the effectiveness of the porous scaffold 
made form silicate bioactive glass (Jones et al. 2006) and composites of phosphate-
based bioactive glasses with PLA (Georgiou et al. 2007). However, in most case it was 
found that in order to reach proper sintering, the temperature to process the scaffolds 
was in the glass crystallization domain. Commercial silicate bioactive glass S53P4 and 
45S5 are prone to crystallization at temperature at which it should be hot formed, inhib-
iting proper particles sintering prior to crystallization (Massera et al. 2012). Crystalliza-
tion was not only found to limit effective particle sintering but to also reduce the glass’ 
bioactivity (Fagerlund et al. 2012a).  
Recent work has shown the ability to control the degradation rate of bioactive glass by 
manipulating its composition. For example, by partially replacing the SiO2 in silicate 
45S5 with B2O3 (yielding a borosilicate bioactive glass), or fully replacing the SiO2 
with B2O3 (producing a borate bioactive glass), the degradation rate can be varied over a 
wide range (Huang et al. 2006). Silicate based bioactive glasses commonly convert 
slowly and incompletely to HA, resulting in the long-term presence of unconverted 
glass in vivo but borate bioactive glass has been found to degrade faster and convert 
more completely to HA (Rahaman et al. 2014). By controlling the glass composition, it 
should be possible to match the degradation rate of borate-based bioactive glass with the 
bone regeneration rate (Rahaman et al. 2011, Greenspan 1999). The bioactivity of the 
glass which is measured by the rate at which it converts to HA, can be varied from 
hours to months, depending on the composition of the glass (Huang et al. 2006). Borate 
bioactive glasses have shown to support cell proliferation and differentiation in vitro as 
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well as tissue infiltration in vivo (Rahaman et al. 2011). Understanding the in vitro 
properties of the glass in SBF and TRIS buffer leads to somewhat approximation of the 
glass behaviors in vivo. 
This thesis consists of a theoretical background presented in chapter 2. This chapter 
gives the key concepts that are relevant to the thesis. Chapter 3 describes the experi-
mental and key methods applied in the thesis. The main results are discussed in Chapter 
4. Conclusion of the thesis is presented in chapter 5 and reports the key findings.  
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2. THEORETICAL BACKGROUND 
2.1 Bioactive glass 
Bioactive glasses are osteoconductive and osteoinductive materials as it supports new 
bone growth along the bone–implant interface as well as within the implant away from 
the bone–implant interface (Rahaman et al. 2011). The glass, when used as implants, is 
generally believed to dissolve completely and help in bone growth, however this does 
not always hold true for all glass compositions and there have been evidence of glass 
remnants even years after implantation (Peltola et al. 2011). The first bioactive glasses 
were within the Na2O-CaO-P2O5-SiO2 oxide-system, and later, K2O, MgO and/or B2O3 
were added to improve the hot-working properties of the glasses (Hench 1996, Brink 
1997). Other elements, such as Ag, Al, Cu, Sr, and Zn, have also been included either 
directly to the glass structure or in coatings on glass to further enhance the antibacterial 
properties and cell response of the glass (Rahaman et al. 2011, Andersson et al. 1990, 
Blaker et al. 2004). Bioactive glasses are used in different forms and size such as mono-
liths, particulates and coatings (Figure 1). The most studied bioactive glasses are sili-
cate, borate and phosphate-based. Since, this thesis is focused mainly on silicate and 
borate glass, a short review of these glasses is given below.  
 
Figure 1: Various product forms manufactured from bioactive glasses with various 
methods (Fagerlund, 2012) 
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2.1.1 Silicate bioactive Glass 
The bioactive glass 45S5 developed by (Hench et al. 1972) and S53P4 glass developed 
by (Andersson et al. 1990) are the most clinically used silicate bioactive glasses. They 
are commercially available as Bioglass® and Bonalive® respectively. Their composition, 
in wt%, is given in Table 1. 
Table 1: Composition of Commercially available Silicate bioactive glass 
Glass SiO2 Na2O CaO P2O5 
45S5 45 24.5 24.5 6 
S53P4 53 23 20 4 
 
There are five stages governing the reaction of silicate bioactive glasses when in contact 
with a physiological medium (Hench, 1991).  
1.  Rapid ion exchange reactions between the glass network modiﬁers (Na+ and 
Ca2+) with H+ (or H3O
+) ions from the solution, leads to hydrolysis of the silica 
groups and the creation of silanol (Si–OH) groups on the glass surface. The pH 
of the solution increases due to the consumption of H+ ions. 
2.  The increase in pH (or OH- concentration) leads to attack of the SiO2 glass net-
work, and the dissolution of silica, in the form of silicic acid, Si(OH)4, into the 
solution, and the continued formation of Si–OH groups on the glass surface. 
3.  Condensation and polymerization of an amorphous SiO2- rich layer on the sur-
face of the glass depleted in Na+ and Ca2+. 
4.  Further dissolution of the glass, coupled with migration of Ca2+ and (PO4)3 ions 
from the glass through the SiO2-rich layer and from the solution, leading to the 
formation of an amorphous calcium phosphate (ACP) layer on the surface of the 
SiO2-rich layer. 
5.  The glass continues to dissolve, as the ACP layer incorporates (OH) and (CO3)2 
from the solution and crystallizes as an HCA layer. 
The first five reaction stages that occur on the glass side of the interface do not de-
pend on the presence of tissues rather they can occur in TRIS-buffer solutions or 
simulated body fluid (SBF) and have been well studied (Hench et al. 1992). Follow-
ing the glass reaction, the tissue/material interaction takes place as shown in Figure 
2. The reaction layers, formed at the surface, enhance adsorption and desorption of 
growth factors (Stage 6) and influence the length of time macrophages are required 
to prepare the implant site for tissue repair (Stage 7) and the attachment (Stage 8) 
and synchronized proliferation and differentiation of osteoblasts (Stage 9). Mineral-
ization of the matrix (Stage10) follows soon thereafter and mature osteocytes, en-
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cased in a collagen-HCA matrix, are the final product by 6–12 days in vitro and in 
vivo (Hench 2006). The later stages depend on the presence of tissues. 
 
 
Figure 2: Sequence of interfacial reactions involved in forming a bond between bone 
and a bioactive glass (Gerhardt et al. 2010) 
In this thesis, the study is mainly focused on the glass/solution interaction. Dissolution 
of the newly developed glasses was studied in TRIS buffer solution and in SBF. The 
TRIS has the advantage over SBF that it is not supersaturated toward the precipitation 
of HA (Bellucci et al. 2011). Thus, studying the dissolution in TRIS allows to further 
understand the speed of release and layer formation induce by the natural dissolution of 
the glass. The SBF allows to increase the speed of reaction by mimicking the composi-
tion of the extracellular part of the blood plasma (Kokubu et al. 2006).  
2.1.2 Borate and borosilicate bioactive glass 
Borate and borosilicate bioactive glass have been prepared, in the past, by varying the 
composition of the silicate based glass by adding boron (partially or fully replacing SiO2 
with B2O3 (Fu et al. 2010, Yao et al. 2007). When compared to silicate glass, borate 
bioactive glass was found to degrade faster and completely convert to HA because of 
their low chemical durability (Huang et al. 2006). The degradation of borate bioactive 
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glasses (without SiO2 in the glass structure) follows a congruent mechanism (Liang et 
al. 2007, Yao et al. 2007). All ions are leached at the same rate, thereby maintaining the 
base glass composition. In the case of borate bioactive glasses, no Si nor B-rich layer is 
form and the HA layer is found to attach directly to the glass surface (Huang et al. 
2006). At biological pH (7.4 ± 0.2), B(OH)3 is the stable species in aqueous solution. 
HPO4 
2- and H2PO4
 - are the stable phosphate species. As borate bioactive glasses dis-
solve in simulated body fluid, the solution pH increases, which would lead to greater 
amounts of HPO4 
2- and B(OH)4 (George 2015). As boric acid is a weaker acid than 
phosphoric acid, release of BO3- ions from the glass, coupled with the consumption of 
PO4
3- ions from the solution and the release of the alkali ions results in an increase of 
pH of the solution (Fu et al. 2010). Although borate glasses have shown to help in cell 
differentiation and cell adhesion in vitro (Huang et al. 2006), toxicity of borate cannot 
be neglected. But studies done on rat with borate bioactive glass have shown the toxici-
ty at an acceptable rate (Zhang et al. 2010). It is supposed that B ions released from 
borate glass with lower concentration < 1.792 mM have little, if any, effect on the cell 
proliferation (Niing et al. 2007). The degradation rate of borate bioactive glass can be 
controlled by replacing SiO2 with B2O3 in silicate bioactive glass (Huang et al. 2006). If 
the composition of these glasses can be tailored, then matching the degradation rate of 
borate-based bioactive glass with the bone regeneration rate should be possible (Ra-
haman et al. 2011).  
2.2 Buffers and Bioactivity 
The ability of bioactive glass to form a chemical bond with bone is generally termed as 
bioactivity. In vitro reactions of bioactive glasses are generally studied in buffered inor-
ganic solutions under static conditions to evaluate whether CaP precipitates on the sam-
ple. CaP precipitation has been used as an indication of in vivo bioactivity (Kokubu et 
al. 2006). The CaP layer is formed by migration of Ca2+ and PO4
3- groups to the glass 
surface and by incorporation of soluble calcium ions and phosphates from the solution 
or simply by precipitation from appropriate solutions (Hench et al. 1991). The CaP lay-
er crystallizes into HA as time progress (Hench et al. 1991). These studies are generally 
performed in TRIS and SBF buffers. On immersion of a bioactive glass in these buffers, 
three general processes occur: leaching, dissolution and precipitation (Kokubu et al. 
2006). Fast leaching results in an increase in the pH of the surrounding solution. The pH 
change varies depending on the glass composition, surface area to volume ratio and agi-
tation rate of the system. By studying the pH change in the solution, a fast and simple 
determination of the in vitro behavior of the glass can be obtained. Though these buffer 
reactions with bioactive glass is comparable to in vivo bioactivity, it should be noted 
that in in vivo condition bioactive glass is exposed to more complex environment of 
proteins and cells.  
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2.2.1 SBF 
SBF is a type of buffer solution that closely resembles the ion concentration of human 
blood plasma, with pH of 7.40 and temperature maintained at 37oC (Kokubu et al. 
1990). The ion concentration of SBF compared to human blood serum is given in table 
2 (Kokubu et al. 2006). Materials that form apatite at their surface upon dissolution in 
SBF can bond to living bone if it does not contain any substance able to induce toxic or 
antibody reaction (Kokubu et al. 2006). 
 
Table 2: Ion concentrations of human blood plasma, SBF and TRIS (mmol/L) 
Ion concentration  Human blood plasma  SBF  TRIS 
Na+ 142.0 142.0 - 
K+ 5.0 5.0 - 
Mg2+ 1.5 1.5 - 
Ca2+ 2.5 2.5 - 
Cl- 103.0 147.8 45 
HCO3- 27.0 4.2 - 
HPO42- 1.0 1.0 - 
SO42- 0.5 0.5 - 
 
However, one should be aware that thermodynamical calculation led to the conclusion 
that SBF is saturated toward the precipitation of apatite crystal. Thus, change in the ion-
ic concentration in the solution may induce precipitation of a Ca-P layer while the bio-
material tested is not bioactive (Bohner & Lemaitre 2009). It is therefore crucial to con-
firm the inherent precipitation of a Ca-P layer using an alternative immersing solution. 
2.2.2 TRIS 
TRIS buffer has been used as a biochemical buffer to study the dissolution behavior of 
bioactive glass (Rohanova et al. 2011). TRIS buffer has shown to increase the glass 
dissolution rate because in TRIS, the amino group acts as a ligand for metal ions able to 
form TRIS-complexed species (Rohanova et al. 2011). Surface reactions of various bio-
active glass in TRIS buffer solution has been studied earlier (Fagerlund et al. 2013, 
Varila et al. 2012) that has shown higher rate of dissolution of bioactive glass in TRIS. 
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The ions present in the TRIS buffer solution as compared to human blood plasma and 
SBF as shown in table 2. However, as no other ions are present in the solution all the 
elements detected in solution upon immersion of the biomaterials can only come from 
the material’s dissolution by products. 
2.3 Hot forming, Sintering and Crystallization 
There are various stages in manufacturing of the glass. The first stage consists in mixing 
the raw material. Each raw material is weighted and mixed in proportion such to obtain 
the expected composition. The second stage is the melting of the raw materials in the 
furnace. The third stage is glass forming, giving the glass required shape as per its ap-
plication. Finally, due to the processing and high temperatures involved in the glass 
processing, there are bound to be thermal stresses in the glass that has been manufac-
tured. Therefore, annealing is done to remove the residual stress (Wallenberger & 
Smrcek 2010). The manufacture of glass is based on cooling the melt so that it will not 
attain the crystalline low-energy state it strives to assume. The temperature at which 
super cooled liquid turns into glass is called the transition temperature or the glass trans-
formation temperature Tg. The liquidus temperature (TL) is the temperature below 
which a single liquid phase is no longer thermodynamically stable (Rawson 1980). 
The way in which the viscosity of a glass changes with temperature is a crucial factor 
determining which forming operations can be used to manufacture at medium to high 
temperature different glass articles. Viscosity of molten glass increases gradually with 
decreasing temperature and approaches an infinite viscosity value as the melt solidifies 
(Arstila 2008). The relation between temperature and viscosity of different bioactive 
glass has been studied (Vedel et al. 2007), as shown in figure 3. In the melting furnace 
the viscosity of the glass melt is in the range of 10 – 102 dPa·s. The commercially im-
portant silicate glasses require melting temperatures of at least 1400 °C to reach this 
viscosity. The melting times are usually several hours in order to ensure homogeneity. 
A viscous melt can then be transformed to a glassy state by rapid cooling called quench-
ing (Arstila 2008).  
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Figure 3: Viscosity dependence on temperature of different Bioactive glass (Vedel et al. 
2007) 
 
Differential thermal analysis (DTA) is often used to determine the characteristic tem-
peratures associated with particular transitions that occur during heating of glasses. Dur-
ing analysis the temperature is varied linearly as a function of time and the difference 
between the glass specimen and an inert reference is measured. The first measurable 
effect is the glass transition temperature Tg, which occurs at a fairly low temperature. 
The temperature Tg corresponds to the inflection point of the first endothermic event, as 
shown in Figure 4, that is caused by the increase in heat capacity. At a slightly higher 
temperature an exothermic peak is usually observed, which is due to crystallization 
(Arstila 2008). Tx, often refers to the onset of crystallization, while Tp corresponds to 
the temperature at which the crystallization peak is maximum. The difference in tem-
perature between the Tg and Tx gives the stable temperature for hot forming operations. 
The wider the range, the easier is the manufacture of bioactive glass products without 
inducing crystallization. Crystallization is known to affect not only the optical proper-
ties of glasses but also their bioactivity (Massera et al. 2014b). Thus, an understanding 
of the effect of chemical composition on the thermal properties of the glass is important 
when developing bioactive glasses, for which hot forming may reveal beneficial in tis-
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sue engineering (Vedel et al. 2007). Most glass-forming melts show some sign of crys-
tallization if held just below the liquidus temperature long enough for structural ar-
rangements to occur. Crystallization can occur either on cooling or reheating, but it al-
ways involves two individual kinetic processes: formation of submicroscopic nuclei, 
and their growth into macroscopic crystals. These two processes are called nucleation 
and crystal growth, respectively (Arstila 2008). XRD technique is used to detect the 
growth of crystals in the glassy matrix. The XRD pattern of an amorphous material is 
distinctly different from the crystalline material and consists of few broad diffuse haloes 
rather than sharp peaks (Padmaja & Kistaiah, 2009). 
 
Figure 4: Ideal DTA curve for the glass represented schematically 
 
Sintering is the process of making a compact and porous mass from the powder form by 
spontaneous adhesion (figure 5). Sintering takes place in two stages (Ristic et al. 2006). 
In the first stage, particles of the powder, which is sintered, are combining. During that 
process the contact surface between particles increases, which in the end results in form-
ing pores in the system. In the second stage, the process of pores overrunning is taking 
place. That's when pores, representing an infinitely huge concentration of point-defects-
vacancies, are decreasing due to diffusion. Sintering mechanism basically takes place as 
a result of viscous flow.  
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Unlike traditional glasses, bioactive glasses have very low silica content which makes 
them vulnerable to crystallize easily at viscosity ranges typically applied in glass form-
ing. Indeed, it was found that heat sintering of the most commercially bioactive glasses 
leads to extended surface crystallization in the best case and to phase-separation prior to 
crystallization in the case of the glass 45S5 (Massera et al. 2012). Upon crystallization, 
typical silicate bioactive glasses showed a decrease in the bioactivity (Fagerlund et al. 
2012a) while crystallization in phosphate bioactive glasses led to complete loss of the 
bioactive properties (Massera et al. 2015). Sintering compositions tolerating thermal 
treatments in the sintering range without crystallization are used for making porous im-
plants by viscous flow sintering. The working range for bioactive glasses could be en-
larged by decreasing the amount of alkali oxides and by increasing the amount of alka-
line earth oxides (Arstila 2008).  
2.4 Scaffold, porosity and Mechanical property 
Porous scaffolds in tissue engineering play an important role in controlling cell function 
and regulating new organ formation (Chen et al. 2002). There have been several design 
criteria as defined by Chen et al. 2002 for making a general tissue engineered scaffold. 
 The surface should permit cell adhesion, promote cell growth, and allow the re-
tention of differentiated cell functions 
 The scaffolds should be biocompatible and the bioactive glass nor its degrada-
tion or leachates should provoke inflammation or toxicity in vivo. 
 The scaffold should be biodegradable and eventually dissolve inside the human 
body.  
 The porosity should be high enough to provide sufficient space for cell adhesion, 
extracellular matrix regeneration, and minimal diffusional constraints during 
culture, and the pore structure should allow even spatial cell distribution 
throughout the scaffold to facilitate homogeneous tissue formation. 
 The material should be able to be processed into 3D structure and it should be 
mechanically strong for intended use.  
Clinical demand for artificial bone graft materials or bioactive scaffolds that can stimu-
late bone regeneration by acting as temporary templates for vascularized bone growth 
Figure 5: Schematic diagram showing pore formation during sintering 
Loose powder 
sintering 
pore 
13 
has been increasing. For better osteogenesis, the scaffold should have an interconnected 
pore structure, with interconnected pore sizes that are greater than 100 µm (Jones et al. 
2003) but subsequent studies have shown better osteogenesis for implants with pores 
>300 μm (Tsuruga et al. 1997). Larger pores favor direct osteogenesis, since they allow 
vascularization and high oxygenation but mechanical properties are compromised in 
larger pore scaffold.  Despite its osteoconductive potential and superior ability to bond 
to bone, the direct application of bioactive glass in load-bearing situations has been lim-
ited. Even though existing bioactive materials possess high compressive strength, they 
are very brittle and have inherently poor tensile and torsional properties (Lu et al. 2003). 
The theoretical strength of flawless solid silicate glass is ~35 GPa (Varshneya 2006). 
The ability of a glass to resist fracture when a crack is present, i.e. fracture toughness, is 
low. Even small flaws lead to the decrease in strength drastically, and typical strength of 
common glass products is only around 14-70 MPa (Varshneya 2006). Depending on the 
composition of the glass, the compressive strength of bioactive silica glasses is around 
800-1200 MPa and tensile bending strength is 40 to 60 MPa (Carter & Norton 2007). 
The compressive strength of cancellous bone is 2-12 MPa and that of cortical bone 100-
230 MPa (Heikkilä 2011). 
Manufacturing a bioactive scaffold having mechanical properties comparable to a load 
bearing bone and having anatomically accurate shape with required porosity is a chal-
lenging task. There are various methods to prepare a porous bioactive scaffold such as 
sol–gel, thermally bonding of particles (fibers or spheres), polymer foam replication, 
freeze casting, and solid freeform fabrication (Fu et al. 2011).  
 The scaffolds made by sol-gel degrade and convert faster to HA than scaffolds from 
melt-derived glass with the same composition. However, these sol–gel derived scaf-
folds have low strength which leads to application only in non-load bearing sites 
(Jones et al. 2006).  
 Scaffolds made by thermal bonding of glass particles has advantage of making scaf-
fold of required geometry, also it doesn’t require complex machinery but the main 
disadvantage of this method is the poor pore inter connectivity (Belluci et al. 2010). 
 The polymer foam replication technique is able to make a scaffold microstructure 
which is similar to that of dry human trabecular bone. Highly porous glass scaffolds 
with open and interconnected porosity in the range 40–95% can be produced from 
this method. Scaffolds of silicate, borosilicate, and borate bioactive glass have been 
prepared using this method (Chen et al. 2006). However, low strength of the scaf-
fold limits its use to the repair of low-load bearing sites.  
 Solid freeform prototyping enables precise manipulation of the 3D architecture, and 
printing of lines as thin as 30 μm using micron-sized glass powders. The sintered 
glass scaffolds, with an anisotropic structure, show a compressive strength (136 
MPa) comparable to human cortical bone, which indicates that these scaffolds have 
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excellent potential for the repair and regeneration of load-bearing bone defects (Fu 
et al. 2011). 
 Freeze casting method can obtain scaffold with high mechanical properties but pore 
width in the range of 10–40 μm which is too small to support tissue ingrowth. Sili-
cate glass scaffolds of compositions 45S5 glass has been prepared using the tech-
nique (Fu et al. 2010). 
Studies have shown that amorphous porous bioactive glass structures can be sintered 
from bioactive glasses having a wide hot-working range (Ylänen 2000). Simple heat 
sintering does not require complex machinery and shapes of the scaffold can be main-
tained by just inserting the glass in powder form in a mould. Desired mechanical prop-
erties and porosities can also be obtained by choosing the right particle size. Taking 
these advantages of sintering, this thesis uses simple heat sintering method for the prep-
aration of scaffold.  
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3. MATERIALS AND METHODS 
3.1 Preparation of glasses 
In this study two set of borosilicate glasses were produced to evidence the impact of 
boron trioxide on the physical, thermal, structural and in vitro properties. In a first time, 
one mol of Silicon was substituted for one mol of Boron. 0.5, 1, 2, 5 and 10 mol% of 
SiO2 was substituted with B2O3, in S53P4 glass. The glasses were labelled 0.5B, 1B, 
2B, 5B and 10B respectively. In a second time, 25%, 50% and 75% of the total SiO2 
content was substituted with B2O3, while maintain CaO, Na2O and P2O5 constant. The 
glasses were labelled B25, B50 and B75 respectively. The glass S53P4 was used as a 
standard reference as it has been well studied in the past (Andersson et al. 1990, Mass-
era et al. 2014a). The composition of the various borosilicate glasses studied is shown 
in the table 3.  
Table 3: Novel borosilicate glass composition (mol %) 
Elements S53P4 0.5B 1B 2B 5B 10B B25 B50 B75 
SiO2 53.86 53.13 52.4 50.94 46.55 39.25 40.40 26.93 13.46 
B2O3 0.00 0.50 1.00 2.00 5.00 10.00 13.46 26.93 40.40 
Na2O 22.66 22.77 22.89 23.11 23.79 24.93 22.66 22.66 22.66 
P2O5 1.72 1.73 1.74 1.75 1.81 1.89 1.72 1.72 1.72 
CaO 21.77 21.87 21.98 22.20 22.85 23.94 21.77 21.77 21.77 
Total 100 100 100.01 100 100 100.01 100 100 100 
 
Glasses were melted from batches containing mixtures of sand (99.4 % pure SiO2), and 
analytical grades of Na2CO3, H3BO3, CaCO3, and CaHPO4.2H2O. The glasses were 
melted in air, in a platinum crucible at temperature from 1000 to 1400 oC depending on 
the boron content. The exact melting procedure used for each glasses are listed in Table 
4. The glasses were then casted into a graphite mould. Successively the ingots were an-
nealed and crushed into powders with <50 µm, 250-500 µm, >500 µm sizes. 
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Table 4: Glass casting protocol used to prepare the glass. 
Glass Temperature  
°C 
Time  
Minutes 
Annealing Temperature  
°C  
 
S53P4 
600 30  
450 1000 30 
1450 120 
 
0.5B 
600 30  
450 1000 30 
1450 120 
 
1B 
600 30  
450 1000 30 
1450 120 
 
2B 
600 30  
450 1000 30 
1450 120 
 
5B 
600 30  
450 1000 30 
1325 90 
 
10B 
600 30  
450 800 30 
1200 90 
 
B25 
600 30  
450 800 40 
1100 60 
1300 120 
B50 
 
600 30  
450 800 30 
1200 30 
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3.2 Preparation of buffers 
Two buffer solutions were used for the glass characterization test: namely SBF and 
TRIS. The SBF was prepared according to the method described by (Kokubu et al. 
1990). The chemicals required for the preparation of SBF are given in Table 5. the 
chemicals were weighed (in the order they are presented in the Table) and introduced in 
a glass beaker containing about 700ml deionized water which was continuously mag-
netically stirred. The reagents were added one after the other ensuring that the previous 
reagent was fully dissolved. Trizma base was carefully mixed in the solution 0.5 mg at a 
time until it fully dissolved. The solution was let to rest for 4 h in a water bath before 
adjusting the pH to 7.40 at 37oC by titrating the solution with 1N HCl. The solution was 
poured in a glass flask and deionized water was added to obtain 1 liter of SBF. The 
flask was shaken and stored in the refrigerator and used within 20 days. 
Table 5: Reagents used to prepare SBF 
Order Reagent Amount 
1 NaCl 7.996 g 
2 NaHCO3 0.350 g 
3 KCl 0.224 g 
4 K2HPO4 0.228 g 
5 MgCl2.6H2O 0.305g 
6 1N-HCl  35 ml 
7 CaCl2 0.278 g 
8 Na2SO4 0.071g 
9 (CH2OH)3NH2 (Trizma Base) 6.057 g 
 
TRIS buffer was prepared as described by Sigma Aldrich to obtain 1 liter of TRIS buff-
er pH 7.40 at 37°C. About 400 ml deionized water was taken in a clean beaker which 
B75 
 
600 30  
450 800 45 
1150 30 
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was continuously magnetically stirred. The reagents (from Sigma Aldrich) listed in ta-
ble 6 was put one after another each reagent about 0.5 g at a time until it fully dissolved. 
Then the solution was left for about 1 hour for thorough mixing. The temperature was 
maintained at 37°C. The solution was then transferred to the 1-liter flask and 1 liter of 
buffer was prepared by adding deionized water and stored in the refrigerator before use. 
The buffer solution was used within 20 days. 
Table 6: Reagents used to prepare TRIS buffer 
Order Reagent Amount 
 
1 Trizma base  1.66 g 
2 Trizma HCL 5.72 g 
3.3 Density 
The density of bulk glass materials was measured by Archimedes’ principle using de-
ionized water. Three repetitions were carried out and average measurements were calcu-
lated. The accuracy was better than 0.03g/cm3. 
3.4 Glass structural analysis 
Fourier transformed infrared spectroscopy (FTIR) in attenuated total reflectance mode 
was employed to evidence the structural change induced by the replacement of SiO2 by 
B2O3 as well as the structural and surface morphology change induce by the glass reac-
tion in SBF and TRIS. FTIR was performed using a Perkin Elmer Spectrum one FTIR 
spectrometer. The resolution used was 4cm-1, and the number of accumulated scan was 
8.  
3.5 Thermal analysis 
The glass transition temperature Tg, the onset of crystallization Tx and the crystallization 
temperature Tp of the glasses were determined using diﬀerential thermal analysis at 
heating rates 10°C/min for glass particle sizes <50 µm (fine powders) and 250–500 µm 
(Coarse powders). The glass transition temperature was taken at the inﬂection point of 
the endotherm, as obtained by taking the ﬁrst derivative of the DTA curve. The crystal-
lization temperature Tp was found at the maximum of the exothermic peak. The accura-
cy of the measurements was ± 3°C. The measurements were performed on 30 mg sam-
ples in platinum pans and in an N2 atmosphere.  
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3.6 In vitro testing 
Glass particulates with grain size < 50 µm and 250-500 µm were immersed in 50 ml of 
simulated body fluid (SBF) and TRIS for 6, 24, 48, 72, and 168 h at 37 oC in an incubat-
ing shaker (INFORS Multitron II). Two parallel samples were taken for each test point.  
In the shaker, the orbital speed of 100 RPM was chosen to give laminar flow mixing of 
the solution without inducing particle movement. The mass of sample immersed in the 
solution was adjusted to give a constant surface area to volume ratio (SA/V≈9.1 X 10-2 
cm2/ml). As the glass was crushed by hand and then sieved, the SA was calculated as-
suming similar average particles size and correcting for the glasses density. The mass 
used varied from 75mg for the S53P4 glass to 72.6 mg for B75 glass. The change in the 
solution pH was recorded for each immersion time and average of the parallel samples 
was calculated. The pH was compared to a blank sample containing only SBF or TRIS. 
After testing, the powder was washed with acetone and dried. The composition and 
structure of the glass powder were analyzed in FTIR. 
3.7 Scaffold processing 
A stainless steel mould with 20 holes (10 mm depth and 5mm diameter) was used to 
prepare the scaffolds. Boron nitride paste was used to coat the internal holes of the 
mould so that the sintered glass particles did not stick in the mould. The effect of sinter-
ing temperature and particle size on the porosity was studied on the most promising 
glasses. The sintering time was maintained constant to 1 hour.  
3.8 Mechanical testing of the scaffold 
Compression testing was performed for the scaffold with the most promising character-
istics in Instron 4411 machine. Three sets of parallel sample were used in the test with 
load cell of 500N and crosshead speed of 0.5mm per minute. The mean and standard 
deviation of the compression strength was calculated.  
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4. RESULTS AND DISCUSSION 
4.1 First glass series 
Glasses with the oxide composition in mol% 53.85SiO2-xB2O3-22.66Na2O-1.72P2O5-
21.77CaO with x varied as (0, 0.5, 1, 2, 5, 10) and maintaining other oxide composition 
according to mole variation in B2O3 were labelled S53P4, 0.5B, 1B, 2B, 5B, 10B re-
spectively. These glasses were prepared using a standard melting. 
4.1.1 Density 
The density of the glass was measured by the Archimedes principle. With an increase in 
the boron content, no noticeable change in the density could be measured, within the 
accuracy of the measurement. The density of all glasses was found to be (2.64 ±0.03) 
g/cm3. The molar volume which represents the space occupied by one mol of glass can 
be expressed as Vm=M/ρ where M is the molecular mass and ρ the density.  With an 
increase in the boron content, the molar volume decreases indicating that the network 
contracts either due to the formation of Si-O-B bonds or due to the formation of a borate 
sub-structure within the silicate network.  
4.1.2 Structural properties 
The FTIR spectrum of the investigated glasses is shown in figure 6. All the spectrum 
where background corrected and normalized to the band with maximum intensity. The 
spectrum of the boron-free glass, S53P4, shows absorption bands at 748, 930, 1023 cm-1 
and in the 1400–1515 cm-1 region. The band at 930 cm-1 can be attributed to Si–O-  and 
the band peaking around 1023 cm-1 to Si–O–Si asymmetric stretching in SiO4 units. The 
band at 748 cm-1 is due to Si–O bending and the band located within the 1400–1515 cm-
1 range is related to carbonate in the glass structure. 
When the boron content increases, new bands appear at 715, 1227 and 1401 cm-1. The 
new band formed at 715 cm-1, the intensity of which increases with an increase of boron 
content, can be attributed to B-O-B bending (Serra et al. 2003, Queiroz et al. 2003, 
Pascuta et al. 2008). The position of the band at 1401 cm-1 shifts to 1380 cm-1 when the 
boron content increases. This band, as well as the shoulder at 1337 cm-1 have been re-
lated to borate triangles BO3 and the band at 1227 cm
-1 to BO2O
- (Serra et al. 2003, 
Pascuta et al. 2008). One can notice that the two bands at 930 and 1023 cm-1 broaden 
with an increase in boron content and have been attributed to a combination of vibration 
modes from BO4 units, B-O-Si and B-O-B linkages, respectively (Serra et al. 2003, 
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Queiroz et al. 2003, Pascuta et al. 2008). Additionally, the band at 748 cm-1 related to 
Si-O bending decreases in intensity and a new band at 715 cm-1 appears and increase in 
intensity. This last band was attributed to B-O-B bending vibration (Serra et al. 2003, 
Queiroz et al. 2003, Pascuta et al. 2008).  
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Figure 6: FTIR spectra of the first series of glasses 
In summary, from the analysis of the FTIR spectra, it is possible to think that with an 
increase of the boron content, the glasses’ structure forms two separate sub-structures: 
one rich in SiO2 and one rich in B2O3.  
4.1.3 Thermal properties 
The DTA thermograms of the glass powders are presented in Figure 7 for the coarse 
powder and Figure 8 for the fine powder. The measurement was performed on both par-
ticles size as, often, change in the crystallization peak shape and intensity with respect 
to the granule size gives information on the crystallization mechanism (Massera et al. 
2012) 
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Figure 7: DTA of coarse glass powders 
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Figure 8: DTA of fine glass powders 
From the DTA thermogram the Tg, Tx and Tp was extracted and are reported in Figure 9 
and 10 for the coarse and fine powder respectively. Tg is represented on the left Y-axis, 
Tx and Tp in the right Y-axis. 
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Figure 9: Tg, Tx and Tp of first series of coarse glass powder 
0 1 2 3 4 5 6 7 8 9 10
490
500
510
520
530
540
550
560
B
2
O
3
 (mol%)
 Tg
 Tx
 Tp
T
e
m
p
e
ra
tu
re
 o
C
580
600
620
640
660
680
700
720
740
T
e
m
p
e
ra
tu
re
 o
C
 
Figure 10: Tg, Tx and Tp of first series of fine glass powder 
With an increase in the boron content the Tg, Tx and Tp decreases. This is in agreement 
with previous studies which showed that B2O3 can be used to decrease the Tg and form-
ing temperatures of glasses (Brink et al. 1997). Also with decreasing the particle size, 
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all characteristic temperature was found to shift toward lower temperature. This is due 
to the thermal lag effect (Massera et al. 2012). Indeed, smaller particles size, have 
smaller volume which would “see” the furnace temperature at earlier time than large 
particles. 
Changes in the shape of the exothermic peak, such as bandwidth and intensity, are usu-
ally indications of a change in the crystallization mechanism (Massera et al. 2012). The 
height of the peak for the investigated glasses is shown in the table 7. One can observe 
that with an increase in boron content, the intensity of the crystallization peak decreases. 
However, the intensity of the peaks did not vary greatly when using fine particles rather 
than large particles. This indicates that the crystallization mechanism of these glasses is 
not particle size dependent (Massera et al. 2012). 
Table 7: Comparison of height of crystallization peak of glass powders 
Glass Peak (A.U.) 
Coarse Powder Fine powder 
S53P4 6.68 6.43 
0.5B 6.45 6.12 
1B 6.06 5.75 
2B 5.94 5.34 
5B 5.73 5.35 
10B 5.34 5.21 
 
Figure 11 shows T, as a function of boron content, which is the difference between Tx 
and Tg. T represents the stability of the glass against crystallization. It can be seen that 
T increases with an increase in boron content indicating that the progressive addition 
of boron increases the glass stability against crystallization. However, one can notice 
that T measured from fine glass powder is smaller than that of the coarse glass pow-
der. This is an indication that the crystallization might be occurring form the surface 
thus coarse particle should be used during sintering of these glass in order to avoid sig-
nificant glass crystallization.  
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Figure 11: Hot forming range for the first series of coarse glass powder 
4.1.4 In vitro dissolution studies 
The first step of the in vitro study was performed in simulated body fluid for the coarse 
and fine powder. Figure 12 presents the change in pH as a function of the time of im-
mersion of the coarse powder whereas Figure 13 presents the change in pH when the 
fine particles are immersed. 
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Figure 12: pH values of coarse glasses in SBF over time. Each point represents mean 
for two parallel samples. 
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Figure 13: pH values of fine glass in SBF over time. Each point represents average for 
three parallel samples. 
In both graphs, an increase in the pH can be seen with increasing the immersion time. 
As explained in the previous section, this can be attributed to the release of alkaline and 
alkaline earth ions from the glass to the solution increasing the solution basicity. With 
an increase in the boron content, the pH rises faster indicating that the initial dissolution 
rate of the boron-containing glasses is faster than the boron-free glass. The boron sub-
network is believed to dissolve at a faster rate than the silicate phase. Indeed, borate 
glasses are known to have faster dissolution rate than the typical silicate bioactive glass-
es (Huang et al. 2006). When comparing the pH change of the coarse and fine powder 
samples, it is noticeable that the final pH is higher when fine powder is used for the ex-
periment. This can be attributed to the higher surface area to volume ratio which leads 
to increased surface in contact with the solution. This in turn implies a faster dissolution 
of the material.  
It is noteworthy that in Figure13, whereas the initial dissolution is greatly higher for the 
glasses labelled 5B and 10B, the final pH does not differ so markedly. Even more, it 
seems that the pH of the B10 glass saturates at 72h of immersions. 
As it is known that SBF is thermodynamically unstable and saturated toward the for-
mation of apatite (Kokubu and Takadama 2005), it is conceivable that upon immersion 
a HCA layer precipitate at the glasses surface. To better understand the dissolution rate 
of the glasses a similar test is performed in TRIS buffer solution. 
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Similar rise of the pH values was observed from the glass powders in the TRIS buffer as 
evidenced from figure 14 for coarse glass powder and Figure 15 for fine glass powder.  
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Figure 14:  pH of coarse glass powders in TRIS. Each point represents mean for two 
parallel samples. 
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Figure 15:  pH of fine glass powders in TRIS. Each point represents mean for two par-
allel samples. 
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The pH of the coarse glass powders linearly rises during the all duration of the immer-
sion test. The B10 glass exhibits the highest pH value confirming the increase in the 
dissolution properties of the boron-containing glasses. Similarly, fine powders in TRIS 
buffer show sharp rise in pH already after 6 hours in TRIS. This is due to the fact that 
large surface area is in contact with the TRIS buffer releasing more ions into the buffer 
solution. It is noteworthy that the pH of fine glass powder remains steady after 72 hours 
in TRIS due, most likely due to the saturation of the TRIS solution with ions leaching 
out form the glasses. The sharp rise in pH in TRIS is due to a faster dissolution of bioac-
tive glass in TRIS than in SBF, which was also observed by (Fagerlund et al. 2013). 
Changes in the glass surface composition as a function of immersion time in SBF and 
TRIS was assessed via FTIR. The spectrum of the S53P4 glass, shown in figure 16, 
exhibits a decrease in band 950 cm-1 as the immersion time increases, revealing a de-
crease in Si-O- and a decrease in SiO4 unit. The presence of the shoulder at 959 cm
−1 
may be attributed to C–O vibration modes in CO32- and to P-O-P bonding (Massera et 
al. 2014a). The presence of phosphate vibrations is further confirmed with the appear-
ance of the shoulder at 875 cm−1 which can be attributed to P-O vibration and the in-
crease in intensity of the band at 1350–1550 cm−1 attributed to carbonate group (Mass-
era et al. 2014a). It is clearly seen that S53P4 forms a carbonated apatite layer when 
immersed in SBF. Hence, the phosphate vibrations can be related to apatite layer for-
mation (HA) and the increase in the band 1350–1550 cm−1 most likely to carbonate sub-
stituted hydroxyapatite irrespective of sample glasses (Massera et al. 2014a). 
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Figure 16: FTIR of  S53P4 fine glass powder immersed at different time in SBF 
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The FTIR spectra of S53P4 glass immersed in TRIS is presented in Figure 17. It can be 
seen that even after one week of immersion clear HA layer is not clearly visible as in 
the SBF. This is due to the fact that TRIS is not supersaturated toward the precipitation 
of HA and may also attribute to the slow formation of HA in silicate glasses.  
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Figure 17: FTIR of S53P4 coarse glass powder immersed at different time in TRIS 
The FTIR spectra of the boron-containing glasses, after immersion in SBF for 48 and 
168h, are presented in figures 18 and 19, respectively. Upon immersion in SBF, the 
bands in the 1200-1600 cm-1 region, corresponding to the borate network, decrease in 
intensity and a doublet in the 1350-1550 cm-1 region appears and increases in intensity 
with an increase in immersion time. The broad band in the 800-1150 cm-1 region splits 
into three well defined bands centered at 1009, 948 and 872 cm-1 after initial immersion. 
For longer immersion, the band at 1009 cm-1 shift to 1019 cm-1 while the position of the 
bands at 948 and 872 cm-1 remain stable. These changes in the FTIR spectra overtime 
show that the B2O3 containing glasses show structural modification where the boron 
network is being hydrolyzed and leached out into the solution with successive precipita-
tion of HCA. 
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Figure 18: FTIR of glass powders immersed 48h in SBF 
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Figure 19: FTIR of glass powders immersed 1 week in SBF 
One can clearly see that the surface structural modification occurs more rapidly (Figure 
18) for the boron containing glasses. HCA is also thicker and more crystallized at the 
surface of the boron containing glasses as evidence in Figure 19 by the lower intensity 
of the shoulder at ~1220 cm-1 related to the silica gel at the interface between the glass 
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and the precipitated layer as well as the increase in intensity, with increasing boron con-
tent, of the carbonate vibration absorption band (Massera et al. 2014a).  
Figure 20 and 21 present the FTIR spectra of the glasses immersed in TRIS for 48 and 
168h. 
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Figure 20: FTIR of glass powders immersed in TRIS 48H 
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Figure 21: Glass immersed in TRIS 1 week 
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As seen in the case of immersion in SBF at 48h corrosion of the borate and silicate net-
work within the glass takes place and precipitation of a calcium phosphate layer precipi-
tate at the surface of the glass surface. It is clear from Figure 20 that the glass containing 
boron precipitates more HA at the glass surface as evidence by the shift and sharpening 
of the main band. However, if at 48 h the absorption related to the vibration of the 
phosphate units are more intense for glass particle immersed in TRIS, at 168 h the FTIR 
signals show less pronounced phosphate vibration when immersed in TRIS than in SBF. 
This is due to the composition of the solutions. The SBF containing a significant 
amount Ca and P is more likely to be saturate at earlier time and to precipitate a thicker 
HCA layer. At the contrary the lack of ions in the TRIS buffer solution leads to a more 
sustain glass dissolution and a delayed layer formation. 
4.2 Second glass series 
Glasses with the oxide composition in mol% 53.85-xSiO2-xB2O3-22.66Na2O-1.72P2O5-
21.77CaO with x varied as 13.46, 26.92 and 40.39 were labelled as B25, B50 and B75. 
The glasses were prepared using a standard melting. Based on the results obtained from 
the previous glass series, the study has been conducted on large particle sizes and in 
SBF. 
4.2.1 Density 
The change in density and molar volume due to the replacement of SiO2 by B2O3 is 
shown in the figure 22. The density of the glass decreases from (2.64±0.03) g/cm3 in 
S53P4 glass to (2.57±0.03) g/cm3 while the molar volume increases when the boron 
content increases from 0 to 75%. Due to the large substitution of SiO2 with B2O3, dras-
tic change in density was recorded. The mass of the sample to be immersed was adjust-
ed to maintain a SA/V = 9.1 10-2 cm/ml. The surface area of the samples was calculated 
based on the density and assuming that the average particle size was independent of the 
glass composition and the particles are spherical. The increase in the molar volume 
tends to indicate that with increasing the SiO2 substitution with sufficient amount of 
B2O3 the glass structure progressively expands. This is due to the fact that the boron 
ions are likely to form B-O-Si, diborate and non-bridging oxygens (NBOs) in the glass 
structure leading to an increase in the free volume within the glass network (Shelby 
2005). Such behavior was not seen in the earlier glasses as the boron content remained 
relatively low.  
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Figure 22: Density and molar volume of the investigated second series of glass 
 
4.2.2 Structural properties 
The FTIR spectra of the investigated glasses are shown in the figure 23. With an in-
crease in boron content, the band at 748 cm-1 related to Si-O bending decreases and a 
new band appears at 715 cm-1, the intensity of which increases. This band has been at-
tributed to B-O-B bending (Serra et al. 2003, Queiroz et al. 2003, Pascuta et al. 2008). 
The band around 1380 cm-1 is due to the BO3 triangle and a shoulder at 1337 cm
-1 and a 
band at 1227 cm-1 appeared due to BO3 (Serra et al. 2003, Queiroz et al. 2003, Pascuta 
et al. 2008) after addition of Boron. It is noteworthy that the absorption bands related to 
the borate network are more intense in this glass system due to the higher boron content 
compared to the previously presented glass series. 
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Figure 23: FTIR spectra of second series of glass powders 
4.2.3 Thermal properties 
Figure 24 shows the DTA thermogram of the investigated glasses, for the coarse parti-
cles. The coarse powder was chosen based on the analysis of the first series of glass. 
Indeed, the use of fine or coarse powder did not show significant changes in the crystal-
lization tendency. The characteristic temperature (Tg, Tx and Tp) are reported in Figure 
25, with Tg shown on the right Y axis and Tx and Tp on the left Y axis. With an increase 
in B2O3 content, the glass transition temperature, Tg, and the onset and maximum crys-
tallization temperatures, Tx and Tp, decrease due to more loosely packed structure ob-
tained when SiO2 is replaced with B2O3. The hot forming range, for the second series of 
glass, is shown in figure 26. Here T presents a maximum of 165 oC for glass B50. Fur-
thermore, the intensity of the crystallization peak was found to decrease for SiO2 substi-
tution up to 50% and then increases for higher B2O3 content, which may indicate that, in 
mixed B2O3/SiO2 glass the crystallization is less prone to occur upon heating.  
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Figure 24: DTA graph for second series of glass 
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Figure 25: Tg, Tx and Tp for the second glass series 
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Figure 26: Hot forming range of second glass series 
4.2.4 In vitro dissolution studies 
Coarse glass particles were immersed in SBF for 6 to 168 hrs. Figure 27 exhibits the pH 
of the SBF as a function of immersion time for all glasses of investigation. An increase 
in B2O3 mol% up to 50 % substitution of SiO2 increases the pH. However, for higher 
B2O3 content, the final pH decreases. As explained earlier, the increase in pH with in-
creasing B2O3 content is due to the faster release of alkali and alkaline earth ions from 
the glass to the solution. The pH for the glass B75 decreases compare to B50 probably 
due to the higher release of boron. Indeed, boron ions in solution tend to make an acidic 
by products which should minimize the rise in pH due to the release of Ca and Na. The 
structural transformation at the surface of the glass’ particles, after immersion in SBF, 
was then studied using FTIR. 
50
70
90
110
130
150
170
190
20 30 40 50 60 70 80
Te
m
p
er
at
u
re
 o
C
B2O3 (mol%) 
Coarse glass
37 
0 20 40 60 80 100 120 140 160 180
7,4
7,5
7,6
7,7
7,8
7,9
8,0
8,1
 
 
p
H
Time (Hours)
 S53P4
 B25
 B50
 B75
 
Figure 27: pH of second series of glass as a function of immersion time. Each point 
represents mean for two parallel samples. 
 
The FTIR spectra of the investigated glasses immersed in SBF for various immersion 
time is given in figure 28, 29 and 30, for the B25, B50 and B75, respectively. When 
compared to the in vitro FTIR dissolution studies of the first series of glass presented in 
chapter 4.1, HCA is thicker and more crystallized at the surface of the boron containing 
glasses with increasing B2O3, as seen by the precipitated layer as well as the increase in 
intensity, with increasing boron content, of the vibration band related to carbonate 
(Massera et al. 2014a). This leads to the conclusion that the second series of glass has 
more affinity towards the HA formation compared to the first series of glass. The sec-
ond series of glass converted to HA at earlier immersion time. The second series of 
glass was hence chosen for the processing of scaffolds, not only because it had good hot 
forming domain but also a quick and more complete conversion to HA. 
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Figure 28: FTIR spectra B25 glass as a function of immersion time 
  
 
Figure 29: FTIR spectra B50 glass as a function of immersion time 
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Figure 30: FTIR spectra B75 glass as a function of immersion time 
 
4.3 Sintering and scaffold 
From the studies of the first and second series of glass, it is clear that the second series 
have the most promising characteristics for preparing scaffold as they possess large hot 
forming domain, low crystallization peaks and rapid conversion to HA. 
4.3.1 Porosity measurement 
Different glass particle sizes (>500 µm, 250-500 µm and <250 µm) were sintered at 
different temperature (570- 620 ºC). The porosity of the scaffolds is shown in figure 31. 
The porosities of glass particles increase with an increase in the particle size when using 
the same sintering temperature. Upon increasing the temperature, the porosity decreases 
due to the increase in the viscous flow sintering. However, at low temperature the glass 
particles do not coalesce to form the scaffold. The optimal porosity of around 50% was 
achieved at 600 ºC for B25 glass, at 580 ºC for B50 glass and at 570 ºC for B75 glass. 
The scaffolds at the porosity of about 50% did not show any crystallization as checked 
using XRD. 
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Figure 31: Porosities of scaffolds at different temperature B25 a) B50 b) and  B75 c). 
Each point represents mean porosities measured in three parallel samples. 
 
4.3.2 Mechanical strength  
The mechanical properties of the glass scaffolds, obtained from sintering of particles in 
the different particle size, with different porosities were measured as illustrated in fig 
32. The mechanical strength decreases drastically for all particle size as the porosity of 
the scaffold increases. This is due to the increase in void space in the scaffold which 
makes the scaffold structurally prone to collapse even at lower mechanical stress. Over-
all 50% porosity was found for the particle size 250-500 µm, which is regarded as an 
optimum porosity for tissue ingrowth. The compressive strength of the scaffolds with 
50% overall porosity was found to range from 3 to 5 MPa, which are close to the one 
for cancellous bone (Heikkilä 2011).  
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Figure 32: Compressive strength and porosity <250µm a), 250-500µm b), >500µm c). 
Each point represents mean for three parallel samples. 
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4.3.3 In vitro test of scaffold 
The sintered scaffolds were immersed in SBF for up to 170h. As shown in figure 33, an 
increase in pH is seen for all tested samples. The high pH value is due to the high poros-
ity of the materials and thus the high SA in contact with the solution. The pH increase is 
maximum for the scaffold with composition B50. The lower increase with increasing 
the boron content to 75% substitution may be due to i) higher B2O3 release into the so-
lution or ii) change in the porosity during dissolution of the scaffolds. 
0 20 40 60 80 100 120 140 160 180
7,4
7,6
7,8
8,0
8,2
8,4
8,6
8,8
 
 
p
H
Time (hour)
 B25
 B50
 B75
 
Figure 33: pH of glass scaffold as a function of immersion time. Each point represents 
mean for three parallel samples. 
The FTIR spectra of the scaffolds are shown in the figure 34. These spectra are similar 
to those of the corresponding glasses (see figure 23). The FTIR spectrum of the scaf-
folds after immersion in SBF are presented in Figures 35 and 36. Already at 6h of im-
mersion, major changes in the main bands within the 900-1200 cm-1 range can be seen. 
This, as expected and explain earlier, is due to the dissolution of the borate and silicate 
network in the solution. Major changes are seen in scaffold B75 due the faster dissolu-
tion of the borate phase compared to the silica phase. However, at one week, the sharp 
peaks corresponding to the phosphate network vibration in HA are well defined for the 
scaffolds B25 and B50, whereas no real modification in the structure can be seen for the 
scaffolds B75 between 6 and 168h of immersion. This indicate that the scaffolds B25 
and B50, effectively convert into HA while the dissolution of the scaffolds B75 was 
slowed down and no significant precipitation of a reactive layer occurred. The reason 
for such abnormal behavior is not yet fully understood and should be investigated in 
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more detailed. Indeed, this glass was expected to convert more rapidly and more com-
pletely into HA than the two other glass composition. One possible reason could be that 
the fast dissolution of the glass leads to large amount of debris that prevent the solution 
form getting in and out of the pores in the scaffolds, thus reducing the SA of the scaf-
fold in contact with the solution.  
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Figure 34: FTIR of scaffold before immersion in SBF 
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Figure 35: FTIR of Scaffold immersed 6h in SBF 
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Figure 36: FTIR of Scaffold immersed 1 week in SBF 
4.3.4 Mechanical properties of scaffold 
The compressive strength of the scaffold before and after the immersion in SBF as a 
function of time is shown in the figure 37. The compressive strength decreases signifi-
cantly, already after 6 hours of immersion. This early decrease in mechanical strength is 
due to the pores present in the scaffold which facilitates the leaching of ions from the 
bulk. This early leaching is also indeed due to the high borate content in the glass scaf-
fold. The glass B25, which is supposed to be the one having the slowest degradation 
rate was also found to maintain mechanical properties similar to cancellous bone for a 
longer time. The glass B75 shows a steep decrease in its mechanical properties already 
at 6 h, similar to the glass B50. This may support our assumption that the glass B75 
reacts too fast at short immersion time which leads to drastic compressive strength drop 
while leading to large amount of debris filling the pores in the scaffolds. 
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Figure 37: Compressive strength of scaffold as a function of immersion time. Each 
point represents mean for three parallel samples. 
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5. CONCLUSION 
In this thesis, the impact of boron substitution on silicate glass composition on the ther-
mal and dissolution properties of bioactive glasses was assessed. In general, In TRIS 
and SBF, addition of boron at the expense of silicate leads to an increase in the dissolu-
tion rate and a more rapid formation of HA in vitro. The hot forming domain was also 
found to be enhanced. Only glasses with 25, 50 and 75 % SiO2 substitution for B2O3 
exhibited a crystallization peaks indicating a decrease in the crystallization rate.  
Scaffolds from these composition (B25, B50 and B75) were processed using simple 
heat sintering using various temperature and three particles sizes. The use of small par-
ticle size led to stronger scaffolds due to a decrease in the average pore size. The use of 
large pore size, at the opposite, led to a decrease in the compressive strength due to in-
crease in the average pore size (at constant overall porosity). However, it is noteworthy 
that all scaffolds processed in this thesis maintain their amorphous nature. The scaffold 
processed with 50% overall porosity using particle size in the range 250 – 500 µm were 
immersed in SBF. While an increase in boron content led to faster HA formation on 
glass particles, the same was not seen in the scaffolds. Indeed, the higher B-containing 
scaffolds was found to degrade rapidly and hence, decrease the mechanical properties.  
The borosilicate glass with higher boron content seems to be promising in terms of apa-
tite formation and fabrication of scaffold by sintering. Porosity required for tissue in-
growth has been achieved without losing bioactive properties. Mechanical properties of 
the scaffold have also been achieved that is comparable to cancellous bone. Overall, this 
study leads a pathway to the development of borosilicate bioactive glass scaffolds 
which should be beneficial to tissue-engineering. 
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